Icon price target raised to $355 from $325 at Barclays

Barclays raised the firm’s price target on Icon to $355 from $325 and keeps an Overweight rating on the shares. The analyst says concerns over demand slowing were likely put to rest by the company’s commentary around requests for proposals accelerating in Q4 and being driven by biotech improving and large pharma demand strength.